VAL-202

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameVAL-202
Drug Alias NameVAL-202
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRC
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesValirx Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesValirx Plc
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A